Regeneron Pharmaceuticals Inc (REGN)

Operating profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	3,990,700	4,047,100	4,738,900	8,946,800	3,576,600
Revenue	US$ in thousands	14,202,000	13,044,200	12,113,500	16,014,400	8,440,200
Operating profit margin		28.10%	31.03%	39.12%	55.87%	42.38%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $3,990,700K ÷ $14,202,000K
= 28.10%

Regeneron Pharmaceuticals Inc's operating profit margin has shown fluctuations over the years based on the provided data. In December 31, 2020, the operating profit margin was reported at 42.38%, which significantly increased to 55.87% by December 31, 2021. However, there was a considerable decline in the operating profit margin to 39.12% by December 31, 2022, and further dropped to 31.03% by December 31, 2023. The downward trend continued as the operating profit margin decreased to 28.10% by December 31, 2024.

The analysis indicates that although Regeneron Pharmaceuticals Inc experienced a notable increase in operating profit margin between 2020 and 2021, there was a subsequent decline in the following years. This trend suggests the need for the company to focus on improving operational efficiency and cost management to sustain and enhance profitability in the future.